Reading Chriopractic & Rehab is categorized under Rehabilitation Center, Outpatient Treatment in Reading, PA and active since 2012.
Reading Chriopractic & Rehab was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 6213100 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 410 South 5th St, Reading, Pennsylvania PA 19602 or by phoning (610) 236-0220. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Reading Chriopractic & Rehab |
Address: | 410 South 5th St, Reading, Pennsylvania 19602 |
Phone Number: | (610) 236-0220 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 6213100 |
Share This Business: |
Reading Chriopractic & Rehab was started in 2012 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 6213100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Reading Chriopractic & Rehab by calling the company number (610) 236-0220, as your correspondence is most welcome. Additionally, the physical location of the single location of Reading Chriopractic & Rehab can be found at the coordinates 40.328881,-75.928252 as well as the street address 410 South 5th St in Reading, Pennsylvania 19602.
For its online presence, you may visit Reading Chriopractic & Rehab’s website at and engage with its social media outlets through on Twitter and on Facebook.